Leukotriene synthesis inhibitors
Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LANGLANDS, John Michael DEBRUIN, Erin YEE, James Gee Ken FONAREV, Julia BURGOYNE, David L |
| description | Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2020206036A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2020206036A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2020206036A13</originalsourceid><addsrcrecordid>eNrjZFDwSS3Nzi8pykzNS1UorswryUgtzixWyMzLyEzKLMkvKuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJQJ0l8Y6hRgYgaGZgbOZoaEycKgAuCiat</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Leukotriene synthesis inhibitors</title><source>esp@cenet</source><creator>LANGLANDS, John Michael ; DEBRUIN, Erin ; YEE, James Gee Ken ; FONAREV, Julia ; BURGOYNE, David L</creator><creatorcontrib>LANGLANDS, John Michael ; DEBRUIN, Erin ; YEE, James Gee Ken ; FONAREV, Julia ; BURGOYNE, David L</creatorcontrib><description>Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210805&DB=EPODOC&CC=AU&NR=2020206036A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210805&DB=EPODOC&CC=AU&NR=2020206036A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LANGLANDS, John Michael</creatorcontrib><creatorcontrib>DEBRUIN, Erin</creatorcontrib><creatorcontrib>YEE, James Gee Ken</creatorcontrib><creatorcontrib>FONAREV, Julia</creatorcontrib><creatorcontrib>BURGOYNE, David L</creatorcontrib><title>Leukotriene synthesis inhibitors</title><description>Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDwSS3Nzi8pykzNS1UorswryUgtzixWyMzLyEzKLMkvKuZhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJQJ0l8Y6hRgYgaGZgbOZoaEycKgAuCiat</recordid><startdate>20210805</startdate><enddate>20210805</enddate><creator>LANGLANDS, John Michael</creator><creator>DEBRUIN, Erin</creator><creator>YEE, James Gee Ken</creator><creator>FONAREV, Julia</creator><creator>BURGOYNE, David L</creator><scope>EVB</scope></search><sort><creationdate>20210805</creationdate><title>Leukotriene synthesis inhibitors</title><author>LANGLANDS, John Michael ; DEBRUIN, Erin ; YEE, James Gee Ken ; FONAREV, Julia ; BURGOYNE, David L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2020206036A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2021</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>LANGLANDS, John Michael</creatorcontrib><creatorcontrib>DEBRUIN, Erin</creatorcontrib><creatorcontrib>YEE, James Gee Ken</creatorcontrib><creatorcontrib>FONAREV, Julia</creatorcontrib><creatorcontrib>BURGOYNE, David L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LANGLANDS, John Michael</au><au>DEBRUIN, Erin</au><au>YEE, James Gee Ken</au><au>FONAREV, Julia</au><au>BURGOYNE, David L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Leukotriene synthesis inhibitors</title><date>2021-08-05</date><risdate>2021</risdate><abstract>Provided are specific leukotriene synthesis inhibitor compounds and pharmaceutical compositions comprising the compounds and methods of using the compounds and the pharmaceutical compositions in treating, for example, inflammatory diseases or conditions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2020206036A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Leukotriene synthesis inhibitors |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T16%3A54%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LANGLANDS,%20John%20Michael&rft.date=2021-08-05&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2020206036A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |